Eric Gowans

• Appointments

  Date	Position	Institution name
  2010 - ongoing	Senior Research Fellow	University of Adelaide, Adelaide
  2008 - 2009	Executive Director	Women's & Children's Health Research Institute, North Adelaide

• Education

  Date	Institution name	Country	Title
  	Napier College	United Kingdom	Fellow of Institute of Medical Laboratory Science
  	University of South Australia, Adelaide	Australia	M. App. Sc.
  	University of Adelaide, Adelaide	Australia	PhD

• Research Interests

  Immunology and Infection Translational Health Outcomes

• Journals

  Year	Citation
  2023	Wijesundara, D. K., Yeow, A., McMillan, C. L. D., Choo, J. J. Y., Todorovic, A., Mekonnen, Z. A., . . . Muller, D. A. (2023). Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine. Molecular Therapy Nucleic Acids, 34, 10 pages. DOI
  2022	Kovoor, J. G., Jacobsen, J. H. W., Duncan, J., Addo, A. A., Tivey, D. R., Babidge, W. J., . . . Maddern, G. J. (2022). Achieving safe surgery after COVID-19 vaccination.. ANZ J Surg, 92(5), 946-949. DOI Scopus3 WoS2
  2022	Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk., B. (2022). SARS-CoV-2 Omicron variant escapes neutralising antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.. Cell Reports Medicine, 3(6), 23 pages. DOI Scopus20 WoS15 Europe PMC20
  2021	Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk, B. (2021). COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection. DOI
  2020	Gummow, J., Masavuli, M., Mekonnen, Z. A., Li, Y., Wijesundara, D. K., Shrestha, A. C., . . . Grubor-Bauk, B. (2020). Safety profile of a multi-antigenic DNA vaccine against hepatitis C virus. Vaccines, 8(1), 1-15. DOI Scopus6 WoS4 Europe PMC4
  2020	Mekonnen, Z. A., Masavuli, M. G., Yu, W., Gummow, J., Whelan, D. M., Al-Delfi, Z., . . . Grubor-Bauk, B. (2020). Enhanced T cell responses induced by a necrotic dendritic cell vaccine, expressing HCV NS3. Front Microbiol, 11, 1-13. DOI Scopus5 WoS3 Europe PMC2
  2019	Grubor-Bauk, B., Wijesundara, D. K., Masavuli, M., Abbink, P., Peterson, R. L., Prow, N. A., . . . Gowans, E. J. (2019). NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice.. Sci Adv, 5(12), eaax2388. DOI Scopus47 WoS36 Europe PMC34
  2019	Roy, S., Jaeson, M., Li, Z., Mahboob, S., Jackson, R., Grubor-Bauk, B., . . . Ranasinghe, C. (2019). Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes. Vaccine, 37(10), 1266-1276. DOI Scopus15 WoS14 Europe PMC13
  2019	Mekonnen, Z. A., Grubor-Bauk, B., Masavuli, M. G., Shrestha, A. C., Ranasinghe, C., Bull, R. A., . . . Wijesundara, D. K. (2019). Toward DNA-based T-cell mediated vaccines to target HIV-1 and hepatitis C virus: approaches to elicit localized immunity for protection. Frontiers in Cellular and Infection Microbiology, 9(APR), 1-8. DOI Scopus10 WoS7 Europe PMC4
  2019	Shrestha, A. C., Wijesundara, D. K., Masavuli, M. G., Mekonnen, Z. A., Gowans, E. J., & Grubor-Bauk, B. (2019). Cytolytic perforin as an adjuvant to enhance the immunogenicity of DNA vaccines. Vaccines, 7(2), 14 pages. DOI Scopus10 WoS11 Europe PMC7
  2019	Masavuli, M. G., Wijesundara, D. K., Underwood, A., Christiansen, D., Earnest-Silveira, L., Bull, R., . . . Grubor-Bauk, B. (2019). A hepatitis C virus DNA vaccine encoding a secreted, oligomerized form of envelope proteins is highly immunogenic and elicits neutralizing antibodies in vaccinated mice. Frontiers in immunology, 10(MAY), 1-19. DOI Scopus29 WoS24 Europe PMC21
  2019	Christiansen, D., Earnest-Silveira, L., Grubor-Bauk, B., Wijesundara, D. K., Boo, I., Ramsland, P. A., . . . Torresi, J. (2019). Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery. Scientific Reports, 9(1), 1-13. DOI Scopus43 WoS33 Europe PMC25
  2019	Mekonnen, Z. A., Grubor-Bauk, B., English, K., Leung, P., Masavuli, M. G., Shrestha, A. C., . . . Wijesundara, D. K. (2019). Single-dose vaccination with a hepatotropic adeno-associated virus efficiently localizes T cell immunity in the liver with the potential to confer rapid protection against Hepatitis C virus. Journal of Virology, 93(19), e00202-19-1-e00202-19-19. DOI Scopus8 WoS8 Europe PMC8
  2018	Wijesundara, D., Gummow, J., Li, Y., Yu, W., Quah, B., Ranasinghe, C., . . . Grubor-Bauk, B. (2018). Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice. Journal of Virology, 92(8), 1-15. DOI Scopus19 WoS19 Europe PMC19
  2018	Christiansen, D., Earnest-Silveira, L., Chua, B., Boo, I., Drummer, H. E., Grubor-Bauk, B., . . . Torresi, J. (2018). Antibody responses to a quadrivalent Hepatitis C viral-like particle vaccine adjuvanted with Toll-like receptor 2 agonists. Viral Immunology, 31(4), 1-6. DOI Scopus9 WoS8 Europe PMC6
  2018	Christiansen, D., Earnest-Silveira, L., Chua, B., Meuleman, P., Boo, I., Grubor-Bauk, B., . . . Torresi, J. (2018). Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine. Scientific Reports, 8(1), 6483-1-6483-13. DOI Scopus32 WoS26 Europe PMC23
  2017	Wijesundara, D., Yu, W., Quah, B., Eldi, P., Hayball, J., Diener, K., . . . Grubor-Bauk, B. (2017). Cytolytic DNA vaccine encoding lytic perforin augments the maturation of- and antigen presentation by- dendritic cells in a time-dependent manner. Scientific Reports, 7(1), 8530-1-8530-8. DOI Scopus7 WoS7 Europe PMC6
  2017	Wijesundara, D., Ranasinghe, C., Grubor-Bauk, B., & Gowans, E. (2017). Emerging targets for developing T cell-mediated vaccines for human immunodeficiency virus (HIV)-1. Frontiers in Microbiology, 8(OCT), 2091-1-2091-7. DOI Scopus10 WoS9 Europe PMC7
  2017	Masavuli, M., Wijesundara, D., Torresi, J., Gowans, E., & Grubor-Bauk, B. (2017). Preclinical development and production of virus-like particles as vaccine candidates for hepatitis C. Frontiers in Microbiology, 8(DEC), 11 pages. DOI Scopus26 WoS19 Europe PMC18
  2016	Tomusange, K., Wijesundara, D., Gummow, J., Wesselingh, S., Suhrbier, A., Gowans, E., & Grubor-Bauk, B. (2016). Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses. Scientific Reports, 6(1), 36658 -1-36658-11. DOI Scopus10 WoS10 Europe PMC8
  2016	Kumar, A., Das, S., Mullick, R., Lahiri, P., Tatineni, R., Goswami, D., . . . Das, S. (2016). Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: a novel VLP prime-adenovirus boost strategy. Vaccine, 34(8), 1115-1125. DOI Scopus20 WoS18 Europe PMC16
  2016	Earnest-Silveira, L., Chua, B., Chin, R., Christiansen, D., Johnson, D., Herrmann, S., . . . Torresi, J. (2016). Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line. Journal of General Virology, 97(8), 1865-1876. DOI Scopus22 WoS20 Europe PMC17
  2016	Tomusange, K., Wijesundara, D., Gummow, J., Garrod, T., Li, Y., Gray, L., . . . Gowans, E. (2016). A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice. Scientific Reports, 6(1), 29131-1-29131-10. DOI Scopus16 WoS16 Europe PMC14
  2016	Earnest-Silveira, L., Christiansen, D., Herrmann, S., Ralph, S., Das, S., Gowans, E., & Torresi, J. (2016). Large scale production of a mammalian cell derived quadrivalent hepatitis C virus like particle vaccine. Journal of Virological Methods, 236, 87-92. DOI Scopus18 WoS16 Europe PMC11
  2016	Jorritsma, S., Gowans, E., Grubor-Bauk, B., & Wijesundara, D. (2016). Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines. Vaccine, 34(46), 5488-5494. DOI Scopus91 WoS79 Europe PMC58
  2016	Grubor-Bauk, B., Yu, W., Wijesundara, D., Gummow, J., Garrod, T., Brennan, A., . . . Gowans, E. (2016). Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs. Gene Therapy, 23(1), 26-37. DOI Scopus24 WoS22 Europe PMC21
  2015	Li, S., Plebanski, M., Smooker, P., & Gowans, E. J. (2015). Editorial: Why vaccines to HIV, HCV, and malaria have so far failed-challenges to developing vaccines against immunoregulating pathogens. Frontiers in Microbiology, 6(NOV), 3 pages. DOI Scopus12 WoS10 Europe PMC12
  2015	Gummow, J., Li, Y., Yu, W., Garrod, T., Wijesundara, D., Brennan, A., . . . Gowans, E. (2015). A multiantigenic DNA vaccine that induces broad hepatitis C virus-specific T-Cell responses in mice. Journal of Virology, 89(15), 7991-8002. DOI Scopus20 WoS22 Europe PMC18
  2015	Tomusange, K., Yu, W., Suhrbier, A., Wijesundara, D., Grubor-Bauk, B., & Gowans, E. (2015). Engineering human rhinovirus serotype-A1 as a vaccine vector. Virus Research, 203, 72-76. DOI Scopus7 WoS6 Europe PMC3
  2014	Yu, W., Grubor-Bauk, B., Mullick, R., Das, S., & Gowans, E. J. (2014). Immunocompetent mouse models to evaluate intrahepatic T cell responses to HCV vaccines. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 10(12), 3576-3578. DOI WoS2
  2014	Gargett, T., Grubor-Bauk, B., Miller, D., Garrod, T., Yu, S., Wesselingh, S., . . . Gowans, E. (2014). Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein. Clinical and Translational Immunology, 3(6), e18-1-e18-7. DOI Scopus19 WoS16 Europe PMC15
  2014	Yu, W., Grubor-Bauk, B., Mullick, R., Das, S., & Gowans, E. J. (2014). Immunocompetent mouse models to evaluate intrahepatic T cell responses to HCV vaccines. Human vaccines & immunotherapeutics, 10(12), 3576-3578. DOI Scopus3 Europe PMC3
  2014	Garrod, T., Grubor-Bauk, B., Yu, S., Gargett, T., & Gowans, E. (2014). Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency.. Human vaccines & immunotherapeutics, 10(9).
  2014	Garrod, T., Gargett, T., Yu, W., Major, L., Burrell, C., Wesselingh, S., . . . Gowans, E. (2014). Loss of long term protection with the inclusion of HIV pol to a DNA vaccine encoding gag. Virus Research, 192, 25-33. DOI Scopus6 WoS6 Europe PMC6
  2014	Garrod, T., Grubor-Bauk, B., Gargett, T., Li, Y., Miller, D., Yu, W., . . . Gowans, E. (2014). DNA vaccines encoding membrane-bound or secreted forms of heat shock protein 70 exhibit improved potency. European Journal of Immunology, 44(7), 1992-2002. DOI Scopus21 WoS18 Europe PMC14
  2014	Beard, M. R., Ffrench, R., Gowans, E. J., Helbig, K. J., Eyre, N. M., Douglas, M. M. W., . . . Drummer, H. E. (2014). A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses. Gastroenterology, 147(1), e1-e4. DOI Scopus1 WoS1
  2014	Garrod, T., Grubor-Bauk, B., Yu, S., Gargett, T., & Gowans, E. (2014). Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency. Human Vaccines and Immunotherapeutics, 10(9), 2679-2683. DOI Scopus9 WoS10 Europe PMC8
  2014	Gargett, T., Grubor-Bauk, B., Garrod, T., Yu, W., Miller, D., Major, L., . . . Gowans, E. (2014). Induction of antigen-positive cell death by the expression of Perforin, but not DTa, from a DNA vaccine enhances the immune response. Immunology and Cell Biology, 92(4), 359-367. DOI Scopus22 WoS23 Europe PMC21
  2014	Yu, W., Grubor-Bauk, B., Gargett, T., Garrod, T., & Gowans, E. (2014). A novel challenge model to evaluate the efficacy of hepatitis C virus vaccines in mice. Vaccine, 32(27), 3409-3416. DOI Scopus14 WoS13 Europe PMC10
  2013	Gouklani, H., Beyer, C., Drummer, H., Gowans, E., Netter, H., & Haqshenas, G. (2013). Identification of specific regions in hepatitis C virus core, NS2 and NS5A that genetically interact with p7 and co-ordinate infectious virus production. Journal of Viral Hepatitis, 20(4), e66-e71. DOI Scopus13 WoS12 Europe PMC11
  2013	Li, S., Lefranc, M., Miles, J., Alamyar, E., Giudicelli, V., Duroux, P., . . . Gowans, E. (2013). IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling. Nature Communications, 4(1), 1-13. DOI Scopus172 WoS147 Europe PMC134
  2012	Li, S., Roberts, S., Plebanski, M., Gouillou, M., Spelman, T., Latour, P., . . . Gowans, E. (2012). Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in Hepatitis C virus infected individuals. PLoS One, 7(8), 1-7. DOI Scopus9 WoS8 Europe PMC7
  2012	Wong, S., Haqshenas, G., Gowans, E., & MacKenzie, J. (2012). The dengue virus M protein localises to the endoplasmic reticulum and forms oligomers. FEBS Letters, 586(7), 1032-1037. DOI Scopus11 WoS11 Europe PMC7
  2012	Gorzin, A., Ramsland, P., Tachedjian, G., & Gowans, E. (2012). Identification of residues involved in NS2 homodimerization and elucidation of their impact on the HCV life cycle. Journal of Viral Hepatitis, 19(3), 189-198. DOI Scopus7 WoS6 Europe PMC5
  2012	Gouklani, H., Bull, R., Beyer, C., Coulibaly, F., Gowans, E., Drummer, H., . . . Haqshenas, G. (2012). Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis. Journal of Virology, 86(9), 5080-5088. DOI Scopus34 WoS37 Europe PMC28
  2011	Wong, S. -S., Chebib, M., Haqshenas, G., Loveland, B., & Gowans, E. J. (2011). Dengue virus PrM/M proteins fail to show pH-dependent ion channel activity in Xenopus oocytes. Virology, 412(1), 83-90. DOI Scopus5 WoS7 Europe PMC5
  2010	Gowans, E., Roberts, S., Jones, K., Dinatale, I., Latour, P., Chua, B., . . . Jackson, D. (2010). A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals. Journal of Hepatology, 53(4), 599-607. DOI Scopus53 WoS46 Europe PMC37
  2009	Meshkat, Z., Audsley, M., Beyer, C., Gowans, E., & Haqshenas, G. (2009). Reverse genetic analysis of a putative, influenze virus M2 HXXXW-like motif in the p7 protein of hepatitis C virus. Journal of Viral Hepatitis, 16(3), 187-194. DOI Scopus20 WoS20 Europe PMC19
  2009	Martyn, J., Cardin, A., Wines, B., Cendron, A., Li, S., MacKenzie, J., . . . Gowans, E. (2009). Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors. Archives of Virology, 154(7), 1129-1138. DOI Scopus32 WoS29 Europe PMC23
  2009	Li, S., Floess, S., Hamann, A., Gaudieri, S., Lucas, A., Hellard, M., . . . Gowans, E. (2009). Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection. PLoS Pathogens, 5(12), 1000707-1-1000707-13. DOI Scopus30 WoS44 Europe PMC26
  2008	Jones, K., Brown, L., Eriksson, E., Ffrench, R., Latour, P., Loveland, B., . . . Gowans, E. (2008). Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors. Journal of Viral Hepatitis, 15(10), 761-772. DOI Scopus12 WoS11 Europe PMC5
  2008	Li, S., Gowans, E., Chougnet, C., Plebanski, M., & Dittmer, U. (2008). Natural Regulatory T Cells and Persistent Viral Infection. Journal of Virology, 82(1), 21-30. DOI Scopus128 WoS120 Europe PMC108
  2008	Chua, B., Eriksson, E., Brown, L., Zeng, W., Gowans, E., Torresi, J., & Jackson, D. (2008). A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection. Vaccine, 26(37), 4866-4875. DOI Scopus49 WoS45 Europe PMC31
  2008	Woollard, D., Haqshenas, G., Dong, X., Pratt, B., Kent, S., & Gowans, E. (2008). Virus-specific T-cell immunity correlates with control of gb virus b infection in marmosets. Journal of Virology, 82(6), 3054-3060. DOI Scopus27 WoS25 Europe PMC24
  2007	Jones, K., Drane, D., & Gowans, E. (2007). Long-term storage of DNA-free RNA for use in vaccine studies. Biotechniques, 43(5), 675-681. DOI Scopus81 WoS69 Europe PMC53
  2007	Chin, R., Earnest-Silveria, L., Koeberlain, B., Franz, S., Zentgraf, H., Dong, X., . . . Torresi, J. (2007). Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: Factors contributing to hepatocarcinogenesis. Journal of Hepatology, 47(3), 325-337. DOI Scopus60 WoS56 Europe PMC47
  2007	Haqshenas, G., Dong, X., Netter, H., Torresi, J., & Gowans, E. (2007). A chimeric GB virus B encoding the hepatitis C virus hypervariable region 1 is infectious in vivo. Journal of General Virology, 88(3), 895-902. DOI Scopus26 WoS23 Europe PMC21
  2007	Li, S., Jones, K., Woollard, D., Dromey, J., Paukovics, G., Plebanski, M., & Gowans, E. (2007). Defining target antigens for CD25⁺FOXP3⁺IFN-γ⁻ regulatory T cells in chronic hepatitis C virus infection. Immunology and Cell Biology, 85(3), 197-204. DOI Scopus56 WoS55 Europe PMC45
  2007	Haqshenas, G., Mackenzie, J., Dong, X., & Gowans, E. (2007). Hepatitis C virus p7 protein is localized in the endoplasmic reticulum when it is encoded by a replication-competent genome. Journal of General Virology, 88(1), 134-142. DOI Scopus37 WoS35 Europe PMC29
  2007	Haqshenas, G., Dong, X., Ewart, G., Bowden, S., & Gowans, E. (2007). A 2a/1b full-length p7 inter-genotypic chimeric genome of hepatitis C virus is infectious in vitro. Virology, 360(1), 17-26. DOI Scopus16 WoS17 Europe PMC15
  2007	Martyn, J., Dong, X., Holmes-Brown, S., Pribul, P., Li, S., Drummer, H., & Gowans, E. (2007). Transient and stable expression of the HCV envelope glycoproteins in cell lines and primary hepatocytes transduced with a recombinant baculovirus. Archives of Virology, 152(2), 329-343. DOI Scopus15 WoS14 Europe PMC9
  2006	Dong, X., Premkumar, A., Haqshenas, G., Gage, P., & Gowans, E. (2006). Amantadine inhibits the function of an ion channel encoded by GB virus-B but fails to inhibit virus replication. Journal of Clinical Virology, 36, S113. DOI
  2006	Premkumar, A., Dong, X., Haqshenas, G., Gage, P. W., & Gowans, E. J. (2006). Amantadine inhibits the function of an ion channel encoded by GB virus B, but fails to inhibit virus replication. Antiviral Therapy, 11(3), 289-295. DOI Scopus13 WoS11 Europe PMC10
  2005	Jackson, D., Deliyannis, G., Eriksson, E., Dinatale, I., & Gowans, E. (2005). Dendritic Cell Immunotherapy of Hepatitis C Virus Infection: Toxicology of Lipopeptide-Loaded Dendritic Cells. International Journal of Peptide Research and Therapeutics, 11(4), 223-235. DOI Scopus8 WoS8
  2005	Mijch, A., Sasadeusz, J., Hellard, M., Dunne, M., McCaw, R., Bowden, S., & Gowans, E. (2005). A study to investigate the impact of the initiation of highly active antiretroviral therapy on the hepatitis C virus viral load in HIV/HCV-coinfected patients. Antiviral Therapy, 10(2), 277-284. DOI Scopus3 WoS3 Europe PMC2
  2004	Gowans, E. J., Jones, K. L., Bharadwaj, M., & Jackson, D. C. (2004). Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus. Journal of Clinical Virology, 30(4), 283-290. DOI Scopus29 WoS27 Europe PMC19
  2004	Li, D., Lott, W. B., Martyn, J., Haqshenas, G., & Gowans, E. J. (2004). Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B <inf>12</inf> and the HCV core protein. Journal of Virology, 78(21), 12075-12081. DOI Scopus15 WoS13 Europe PMC14
  2004	Torresi, J., Bharadwaj, M., Jackson, D. C., & Gowans, E. J. (2004). Neutralising antibody, CTL and dendritic cell responses to hepatitis C virus: A preventive vaccine strategy. Current Drug Targets, 5(1), 41-56. DOI Scopus19 WoS20 Europe PMC14
  2003	Ward, S. M., Tindle, R. W., Khromykh, A. A., & Gowans, E. J. (2003). Generation of CTL responses using Kunjin replicon RNA. Immunology and Cell Biology, 81(1), 73-78. DOI Scopus4 WoS4 Europe PMC3
  2003	Fowler, N. L., Torresi, J., Jackson, D. C., Brown, L. E., & Gowans, E. J. (2003). Immune responses in hepatitis C virus infection: The role of dendritic cells. Immunology and Cell Biology, 81(1), 63-66. DOI Scopus10 WoS8 Europe PMC9
  2003	Chuan, B. Y., Healy, A., Cameron, P. U., Stock, O., Rizkalla, M., Zeng, W., . . . Jackson, D. C. (2003). Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus. Immunology and Cell Biology, 81(1), 67-72. DOI Scopus33 WoS32 Europe PMC16
  2003	Netter, H. J., Woo, W. P., Tindle, R., Macfarlan, R. I., & Gowans, E. J. (2003). Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine. Vaccine, 21(21-22), 2692-2697. DOI Scopus28 WoS22 Europe PMC19
  2003	Li, D., Takyar, S. T., Lott, W. B., & Gowans, E. J. (2003). Amino acids 1-20 of the hepatitis C virus (HCV) core protein specifically inhibit HCV IRES-dependent translation in HepG2 cells, and inhibit both HCV IRES- and cap-dependent translation in HuH7 and CV-1 cells. Journal of General Virology, 84(4), 815-825. DOI Scopus37 WoS34 Europe PMC28
  2002	Greive, S. J., Webb, R. I., Mackenzie, J. M., & Gowans, E. J. (2002). Expression of the hepatitis C virus structural proteins in mammalian cells induces morphology similar to that in natural infection. Journal of Viral Hepatitis, 9(1), 9-17. DOI Scopus14 WoS12 Europe PMC4
  2002	Takyar, S. S., Gowans, E. J., & Lott, W. B. (2002). Vitamin B12 stalls the 80 S ribosomal complex on the hepatitis C internal ribosome entry site. Journal of Molecular Biology, 319(1), 1-8. DOI Scopus18 WoS15 Europe PMC11
  2001	Lott, W. B., Takyar, S. S., Tuppen, J., Crawford, D. H. G., Harrison, M., Sloots, T. P., & Gowans, E. J. (2001). Vitamin B12 and hepatitis C: Molecular biology and human pathology. Proceedings of the National Academy of Sciences of the United States of America, 98(9), 4916-4921. DOI Scopus35 WoS32 Europe PMC25
  2001	Ward, S. M., Macnaughton, T. B., & Gowans, E. J. (2001). Development and characterisation of recombinant hepatitis delta virus-like particles. Virus Genes, 23(1), 97-104. DOI Scopus2 WoS2 Europe PMC1
  2001	Netter, H. J., Macnaughton, T. B., Woo, W. P., Tindle, R., & Gowans, E. J. (2001). Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes. Journal of Virology, 75(5), 2130-2141. DOI Scopus81 WoS71 Europe PMC52
  2000	Takyar, S. T., Li, D. S., Wang, Y. H., Trowbridge, R., & Gowans, E. J. (2000). Specific detection of minus-strand hepatitis C virus RNA by reverse- transcription polymerase chain reaction on polyA<sup>+</sup>-purified RNA. Hepatology, 32(2), 382-387. DOI Scopus33 WoS32 Europe PMC28
  2000	Warrilow, D., Lott, W. B., Greive, S., & Gowans, E. J. (2000). Properties of the bovine viral diarrhoea virus replicase in extracts of infected MDBK cells. Archives of Virology, 145(10), 2163-2171. DOI Scopus8 WoS8 Europe PMC5
  2000	Gowans, E. J. (2000). Distribution of markers of hepatitis C virus infection throughout the body. Seminars in Liver Disease, 20(1), 85-102. DOI Scopus90 WoS77 Europe PMC55
  1999	Harvey, T. J., Macnaughton, T. B., Park, D. S., & Gowans, E. J. (1999). A cellular protein which binds hepatitis B virus but not hepatitis B surface antigen. Journal of General Virology, 80(3), 607-615. DOI Scopus7 WoS3 Europe PMC2
  1998	Gong, Y., Shannon, A., Westaway, E. G., & Gowans, E. J. (1998). The replicative intermediate molecule of bovine viral diarrhoea virus contains multiple nascent strands. Archives of Virology, 143(2), 399-404. DOI Scopus17 WoS17 Europe PMC8
  1998	Gong, Y., Trowbridge, R., MacKintosh, S., Shannon, A., & Gowans, E. J. (1998). A stable cell line with a proportion of cells persistently infected with bovine viral diarrhoea virus. Veterinary Microbiology, 63(2-4), 117-124. DOI Scopus3 WoS3 Europe PMC3
  1998	Trowbridge, R., & Gowans, E. J. (1998). Molecular cloning of an Australian isolate of hepatitis C virus. Archives of Virology, 143(3), 501-511. DOI Scopus18 WoS19 Europe PMC16
  1998	Trowridge, R., & Gowans, E. J. (1998). Identification of novel sequences at the 5′ terminus of the hepatitis C virus genome. Journal of Viral Hepatitis, 5(2), 95-98. DOI Scopus13 WoS13 Europe PMC10
  1998	Hyland, C. A., Mison, L., Solomon, N., Cockerill, J., Wang, L., Hunt, J., . . . Gowans, E. J. (1998). Exposure to GB virus type C or hepatitis G virus in selected Australian adult and children populations. TRANSFUSION, 38(9), 821-827. DOI WoS22 Europe PMC19
  1998	Selvey, L. A., Hyland, C. A., Mison, L., Solomon, N., & Gowans, E. J. (1998). Is there evidence for vector transmission of GBV-C?. Lancet, 351(9109), 1104-1105. DOI Scopus6 WoS7 Europe PMC7
  1997	Harvey, T. J., Macnaughton, T. B., & Gowans, E. J. (1997). The development and characterisation of a SV40 T-antigen positive cell line of human hepatic origin. Journal of Virological Methods, 65(1), 67-74. DOI Scopus9 WoS7 Europe PMC6
  1997	Wang, Y. H., Trowbridge, R., & Gowans, E. J. (1997). Expression and interaction of the hepatitis C virus structural proteins and the 5' untranslated region in baculovirus infected cells. Archives of Virology, 142(11), 2211-2223. DOI Scopus5 WoS5 Europe PMC3
  1997	Atkins, G., Qiao, M., Coombe, D., Gowans, E., & Ashman, L. (1997). Hepatitis B virus binding to leucocyte plasma membranes utilizes a different region of the preS1 domain to the hepatocyte receptor binding site and does not require receptors for opsonins.. Immunology and Cell Biology, 75(3), 259-266. DOI Scopus3 WoS1
  1996	Beardsley, A., Gowans, E., Burrell, C., & Marmion, B. (1996). Enhanced amplification of hepatitis C virus (HCV) cDNA by PCR: Detection of HCV RNA in archival sera. Journal of Clinical Microbiology, 34(6), 1581-1582. DOI Scopus2 WoS2 Europe PMC1
  1996	Gong, Y., Trowbridge, R., Macnaughton, T. B., Westaway, E. G., Shannon, A. D., & Gowans, E. J. (1996). Characterization of RNA synthesis during a one-step growth curve and of the replication mechanism of bovine viral diarrhoea virus. Journal of General Virology, 77(11), 2729-2736. DOI Scopus73 WoS70 Europe PMC45
  1996	Trowbridge, R., Sloots, T. P., Buda, P., Faoagali, J., Hyland, C., Young, I., & Gowans, E. J. (1996). An ELISA for the detection of antibody to the core antigen of hepatitis C virus: Use in diagnosis and analysis of indeterminate samples. Journal of Hepatology, 24(5), 532-538. DOI Scopus4 WoS5 Europe PMC3
  1996	Beard, M. R., MacNaughton, T. B., & Gowans, E. J. (1996). Identification and characterization of a hepatitis delta virus RNA transcriptional promoter. Journal of Virology, 70(8), 4986-4995. DOI Scopus65 WoS62 Europe PMC46
  1996	Blight, K., Trowbridge, R., & Gowans, E. J. (1996). Absence of double-stranded replicative forms of HCV RNA in liver tissue from chronically infected patients. Journal of Viral Hepatitis, 3(1), 29-36. DOI Scopus8 WoS8 Europe PMC3
  1994	Qiao, M., Macnaughton, T. B., & Gowans, E. J. (1994). Adsorption and penetration of hepatitis B virus in a nonpermissive cell line. Virology, 201(2), 356-363. DOI Scopus39 WoS37 Europe PMC23
  1994	MENG, Z., XU, D., SUN, D., LU, H., COPLAND, J., LIU, C., . . . GOWANS, E. J. (1994). A study of primary‐ and re‐infection with hepatitis C virus in blood transfusion recipients. Journal of Gastroenterology and Hepatology, 9(3), 211-216. DOI
  1994	McGuinness, P. H., Bishop, G. A., McCaughan, G. W., Trowbridge, R., & Gowans, E. J. (1994). False detection of negative-strand hepatitis C virus RNA. The Lancet, 343(8896), 551-552. DOI Scopus68 WoS68 Europe PMC18
  1994	Beardsley, A. M., LaBrooy, J. T., Rozen, L., & Gowans, E. J. (1994). A comparison of hepatitis C virus (HCV) RNA and – antibody as markers of infection and predictors of infectivity. Australian and New Zealand Journal of Medicine, 24(2), 182-187. DOI Scopus10 WoS9 Europe PMC3
  1994	MENG, Z., SUN, Y., SUN, D., LIU, C., COPLAND, J., & GOWANS, E. J. (1994). A dynamic study of viraemia in chronic hepatitis C infection. Journal of Gastroenterology and Hepatology, 9(3), 242-244. DOI Scopus4 WoS4 Europe PMC2
  1994	Gowans, E. J., Blight, K., Arthur, J., & Higgins, G. D. (1994). Detection of virus nucleic acids by radioactive and nonisotopic in situ hybridization.. Methods in molecular biology (Clifton, N.J.), 33, 243-256. DOI Scopus1 Europe PMC1
  1994	Gowans, E. J., Arthur, J., Blight, K., & Higgins, G. D. (1994). Application of in situ hybridization for the detection of virus nucleic acids.. Methods in molecular biology (Clifton, N.J.), 33, 395-408. DOI
  1994	Blight, K., Lesniewski, R. R., Labrooy, J. T., & Gowans, E. J. (1994). Detection and distribution of hepatitis C—specific antigens in naturally infected liver. Hepatology, 20(3), 553-557. DOI Scopus38 WoS44 Europe PMC25
  1993	Gowans, E. J., & Bonino, F. (1993). Hepatitis delta virus pathogenicity.. Progress in clinical and biological research, 382, 125-130. Scopus19 Europe PMC7
  1993	Blight, K., Lesniewski, R., LaBrooy, J., Trowbridge, R., & Gowans, E. (1993). Localisation of hepatitis C virus proteins in infected liver tissue by immunofluorescence. Gastroenterologia Japonica, 28(5 Supplement), 55-58. DOI Scopus8 Europe PMC7
  1993	Cole, S. M., Macnaughton, T. B., & Gowans, E. J. (1993). Differential roles for HDAg-p24 and -p27 in HDV pathogenesis.. Progress in clinical and biological research, 382, 131-138. Scopus7 Europe PMC4
  1993	Dammacco, F., Sansonno, D., Beardsley, A., & Gowans, E. J. (1993). Failure to detect hepatitis C virus (HCV) genome by polymerase chain reaction in human anti-HCV-positive intravenous immunoglobulins. Clinical and Experimental Immunology, 92(2), 205-210. DOI Scopus9 WoS9 Europe PMC3
  1993	Blight, K., Rowland, R., De La Hall, P. M., Lesniewski, R. R., Trowbridge, R., LaBrooy, J. T., & Gowans, E. J. (1993). Immunohistochemical detection of the NS4 antigen of hepatitis C virus and its relation to histopathology. American Journal of Pathology, 143(6), 1568-1573. Scopus36 WoS36 Europe PMC20
  1993	Hardiman, R. P., Shaw, D. R., Brooy, J. T. L., Rozen, L., de Boer, W. B., Rowland, R., . . . Gowans, E. J. (1993). Chronic liver disease in asymptomatic hepatitis C antibody positive blood donors. Australian and New Zealand Journal of Medicine, 23(2), 176-180. DOI Scopus12 WoS14 Europe PMC5
  1993	Macnaughton, T. B., Beard, M. R., Chao, M., Gowans, E. J., & Lai, M. M. C. (1993). Endogenous Promoters Can Direct the Transcription of Hepatitis Delta Virus RNA from a Recircularized cDNA Template. Virology, 196(2), 629-636. DOI Scopus37 WoS34 Europe PMC23
  1992	Sumathy, S., Thyagarajan, S. P., Latif, R., Madanagopalan, N., Raguram, K., Rajasambandam, P., & Gowans, E. (1992). A dipstick immunobinding enzyme-linked immunosorbent assay for serodiagnosis of hepatitis B and delta virus infections. Journal of Virological Methods, 38(1), 145-152. DOI Scopus11 WoS11 Europe PMC7
  1992	Gowans, E. J. (1992). Autoradiographic detection of radiolabelled probes by in situ hybridizaiton. Liver, 12(4), 238-242. DOI Scopus3 WoS3 Europe PMC2
  1992	Bilght, K., Trowbridge, R., Rewland, R., & Gowans, E. (1992). Detection of hepatitis C virus RNA by in situ hybridizaiton. Liver, 12(4), 286-289. DOI Scopus35 WoS39 Europe PMC22
  1992	Qiao, M., Gowans, E. J., & Burrell, C. J. (1992). Intracellular factors, but not virus receptor levels, influence the age-related outcome of DHBV infection of ducks. Virology, 186(2), 517-523. DOI Scopus10 WoS10 Europe PMC6
  1992	BEARDSLEY, A. M., BLIGHT, K., GOWANS, E. J., LABROOY, J. T., ROZEN, L., & BURRELL, C. J. (1992). HEPATITIS-C VIRUS-INFECTION IN BLOOD-DONORS - EVIDENCE FOR 2 GROUPS OF ANTI-HCV-POSITIVE INDIVIDUALS. HEPATOLOGY, 16(2), 515.
  1991	MacNaughton, T. B., Gowans, E. J., McNamara, S. P., & Burrell, C. J. (1991). Hepatitis δ antigen is necessary for access of hepatitis s virus rna to the cell transcriptional machinery but is not part of the transcriptional complex. Virology, 184(1), 387-390. DOI Scopus79 WoS82 Europe PMC57
  1991	Gaughwin, M. D., Gowans, E., Ali, R., & Burrell, C. (1991). Bloody needles: The volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS, 5(8), 1025-1027. DOI Scopus47 WoS51 Europe PMC27
  1991	Cole, S. M., Gowans, E. J., Macnaughton, T. B., De La M. Hall, P., & Burrell, C. J. (1991). Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen. Hepatology, 13(5), 845-851. DOI Scopus71 WoS54 Europe PMC43
  1990	Qiao, M., Gowans, E. J., Bailey, S. E., Jilbert, A. R., & Burrell, C. J. (1990). Serological analysis of duck hepatitis B virus infection. Virus Research, 17(1), 3-13. DOI Scopus15 WoS16 Europe PMC11
  1990	Gowans, E. J., Macnaughton, T. B., Mickan, L., Jilbert, A. R., & Burrell, C. J. (1990). Use of recombinant hepatitis delta antigen in diagnostic assays for HDV antibody. Journal of Virological Methods, 27(1), 69-78. DOI Scopus4 WoS3 Europe PMC3
  1990	Macnaughton, T. B., Gowans, E. J., Reinboth, B., Jilbert, A. R., & Burrell, C. J. (1990). Stable expression of hepatitis delta virus antigen in a eukaryotic cell line. Journal of General Virology, 71(6), 1339-1345. DOI Scopus39 WoS40 Europe PMC29
  1990	Macnaughton, T. B., Gowans, E. J., Albert, A. R., & Burrell, C. J. (1990). Hepatitis delta virus RNA, protein synthesis and associated cytotoxicity in a stably transfected cell line. Virology, 177(2), 692-698. DOI Scopus65 WoS65 Europe PMC49
  1990	Niu, J., Wang, Y., Qiao, M., Gowans, E., Edwards, P., Thyagarajan, S. P., . . . Locarnini, S. (1990). Effect of Phyllanthus amarus on duck hepatitis B virus replication in vivo. Journal of Medical Virology, 32(4), 212-218. DOI Scopus29 Europe PMC18
  1990	Gowans, E., Macnaughton, T., & Burrel, C. (1990). Hepatitis delta virus. Today's Life Science, 2(9), 48-54.
  1988	Freiman, J. S., Jilbert, A. R., Dixon, R. J., Holmes, M., Gowans, E. J., Burrell, C. J., . . . Cossart, Y. E. (1988). Experimental duck hepatitis B virus infection: Pathology and evolution of hepatic and extrahepatic infection. Hepatology, 8(3), 507-513. DOI Scopus61 WoS61 Europe PMC43
  1988	FREIMAN, J. S., JILBERT, A. R., BURRELL, C. J., HOLMES, M., GOWANS, E. J., HALL, P., & COSSART, Y. E. (1988). EARLY VIRUS-CELL INTERACTIONS IN HEPADNAVIRUS INFECTION. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 18(3), 413.
  1988	Jilbert, A. R., Freiman, J. S., Burrell, C. J., Holmes, M., Gowans, E. J., Rowland, R., . . . Cossart, Y. E. (1988). Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver. Gastroenterology, 95(5), 1375-1382. DOI Scopus38 WoS33 Europe PMC26
  1988	Gowans, E. J., Baroudy, B. M., Negro, F., Ponzetto, A., Purcell, R. H., & Gerin, J. L. (1988). Evidence for replication of hepatitis delta virus RNA in hepatocyte nuclei after in vivo infection. Virology, 167(1), 274-278. DOI Scopus51 WoS51 Europe PMC42
  1988	Korba, B. E., Gowans, E. J., Wells, F. V., Tennant, B. C., Clarke, R., & Gerin, J. L. (1988). Systemic distribution of woodchuck hepatitis virus in the tissues of experimentally infected woodchucks. Virology, 165(1), 172-181. DOI Scopus40 WoS41 Europe PMC31
  1988	Gowans, E. J. (1988). Strategies for in situ hybridization. La Ricerca in Clinica e in Laboratorio, 18(2-3), 171-176. DOI Scopus1
  1988	LAWSON, M. J., FOCK, K. M., GOWANS, E. J., MATHEW, T. H., & BURRELL, C. J. (1988). Hepatitis B in renal transplant recipients: An assessment of the relationship of viral replication to liver pathology. Journal of Gastroenterology and Hepatology, 3(1), 47-53. DOI Scopus2 WoS2
  1987	Taylor, J., Mason, W., Summers, J., Goldberg, J., Aldrich, C., Coates, L., . . . Gowans, E. (1987). Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes. Journal of Virology, 61(9), 2891-2895. DOI Scopus101 WoS110 Europe PMC70
  1987	JILBERT, A. R., FREIMAN, J. S., BURRELL, C. J., HOLMES, M., GOWANS, E. J., ROWLAND, R., . . . COSSART, Y. E. (1987). VIRUS-CELL INTERACTIONS IN DUCK HEPATITIS-B VIRUS-INFECTION OF PEKIN-AYLESBURY DUCKS - AN INSITU STUDY OF DHBV DNA, RNA, AND DHBSAG. JOURNAL OF MEDICAL VIROLOGY, 21(4), A75-A76.
  1987	FREIMAN, J., JILBERT, A., HOLMES, M., GOWANS, E., BURRELL, C., & COSSART, Y. (1987). DUCK HEPATITIS-B VIRUS - SEQUENCE AND SIGNIFICANCE OF LYMPHOID SYSTEM INFECTION. JOURNAL OF MEDICAL VIROLOGY, 21(4), A75.
  1987	Jilbert, A. R., Freiman, J. S., Gowans, E. J., Holmes, M., Cossart, Y. E., & Burrell, C. J. (1987). Duck hepatitis B virus DNA in liver, spleen, and pancreas: Analysis by in situ and southern blot hybridization. Virology, 158(2), 330-338. DOI Scopus62 WoS55 Europe PMC45
  1986	Jilbert, A. R., Hertzog, P. J., Burrell, C. J., Gowans, E. J., Linnane, A. W., & Marmion, B. P. (1986). Production of a monoclonal antibody to human interferon-α (IFN-α) and its use to identify IFN-α-producing cells in virus infection in vivo. Microbial Pathogenesis, 1(2), 159-168. DOI Scopus25 WoS29 Europe PMC22
  1986	Jilbert, A. R., Burrell, C. J., Gowans, E. J., Hertzog, P. J., Linnane, A. W., & Marmion, B. P. (1986). Cellular localization of α‐interferon in hepatitis B virus‐infected liver tissue. Hepatology, 6(5), 957-961. DOI Scopus44 WoS42 Europe PMC30
  1986	LAWSON, M. J., FOCK, K. M., GOWANS, E., MATHEW, T., & BURRELL, C. J. (1986). HEPATITIS-B IN RENAL-TRANSPLANT RECIPIENTS - AN ASSESSMENT OF THE RELATIONSHIP OF VIRAL REPLICATION TO LIVER PATHOLOGY. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 16(4), 597.
  1986	Jilbert, A. R., Burrell, C. J., Gowans, E. J., & Rowland, R. (1986). Histological aspects of in situ hybridization - Detection of poly(A) nucleotide sequences in mouse liver sections as a model system. Histochemistry, 85(6), 505-514. DOI Scopus20 WoS24 Europe PMC15
  1986	Gowans, E. J. (1986). Relationship between HBeAg and HBV DNA in patients with acute and persistent hepatitis B infection. Medical Journal of Australia, 145(9), 439-441. DOI Scopus19 WoS19 Europe PMC13
  1985	Gowans, E. J., Burrell, C. J., Jilbert, A. R., & Marmion, B. P. (1985). Cytoplasmic (But not nuclear) hepatitis b virus (hbv) core antigen reflects hbv dna synthesis at the level of the infected hepatocyte. Intervirology, 24(4), 220-225. DOI Scopus47 WoS46 Europe PMC38
  1985	Gowans, E. J., & Burrell, C. J. (1985). Widespread presence of cytoplasmic HBcAg in hepatitis B infected liver detected by improved immunochemical methods. Journal of Clinical Pathology, 38(4), 393-398. DOI Scopus46 WoS48 Europe PMC29
  1985	Burrell, C. J., Gowans, E. J., & Marmion, B. P. (1985). HIGH LEVELS OF CYTOPLASMIC HEPATITIS B CORE ANTIGEN AS RELIABLE MARKER OF HBV DNA REPLICATION. The Lancet, 325(8426), 454-455. DOI Scopus9 WoS10 Europe PMC7
  1984	Burrell, C. J., Gowans, E. J., Rowland, R., Hall, P., Jilbert, A. R., & Marmion, B. P. (1984). Correlation Between Liver Histology and Markers of Hepatitis B Virus Replication in Infected Patients: A Study by In Situ Hybridization. Hepatology, 4(1), 20-24. DOI Scopus56 WoS68 Europe PMC43
  1983	Gowans, E. J., Burrell, C. J., Jilbert, A. R., & Marmion, B. P. (1983). Patterns of single- and double-stranded hepatitis B virus DNA and viral antigen accumulation in infected liver cells. Journal of General Virology, 64(6), 1229-1239. DOI Scopus38
  1983	GOWANS, E. J., BURRELL, C. J., JILBERT, A. R., & MARMION, B. P. (1983). PATTERNS OF SINGLE-STRANDED AND DOUBLE-STRANDED HEPATITIS-B VIRUS-DNA AND VIRAL-ANTIGEN ACCUMULATION IN INFECTED LIVER-CELLS. JOURNAL OF GENERAL VIROLOGY, 64(JUN), 1229-1239. DOI WoS45 Europe PMC28
  1982	BURRELL, C. J., GOWANS, E. J., JILBERT, A. R., LAKE, J. R., & MARMION, B. P. (1982). HEPATITIS-B VIRUS-DNA DETECTION BY INSITU CYTOHYBRIDIZATION - IMPLICATIONS FOR VIRAL REPLICATION STRATEGY AND PATHOGENESIS OF CHRONIC HEPATITIS. HEPATOLOGY, 2(2), S85-S91. WoS37
  1982	Burrell, C., Gowans, E., & Jilbert, A. (1982). Hepatitis B virus DNA detection by in situ cytohybridization: Implications for viral replication strategy and pathogenesis of chronic hepatitis. Hepatology, 2(2 Suppl.). Scopus32
  1981	Gowans, E. J., Burrell, C. J., Jilbert, A. R., & Marmion, B. P. (1981). Detection of hepatitis B virus DNA sequences in infected hepatocytes by in situ cytohybridisation. Journal of Medical Virology, 8(1), 67-78. DOI Scopus35 WoS38 Europe PMC22
  1979	GOWANS, E. J., & MCNULTY, M. S. (1979). NOVEL TUBULAR AND CRYSTALLINE-STRUCTURES IN PURIFIED PREPARATIONS OF NEWCASTLE-DISEASE VIRUS. ARCHIVES OF VIROLOGY, 62(4), 353-356. DOI
  1977	MCNULTY, M. S., GOWANS, E. J., LOUZA, A. C., & FRASER, G. (1977). ELECTRON-MICROSCOPIC STUDY OF MDBK CELLS PERSISTENTLY INFECTED WITH NEWCASTLE-DISEASE VIRUS. ARCHIVES OF VIROLOGY, 53(3), 185-195. DOI WoS6 Europe PMC2
  1975	MCNULTY, M. S., GOWANS, E. J., HOUSTON, M. J., & FRASER, G. (1975). NEURAMINIDASE CONTENT OF STRAINS OF NEWCASTLE-DISEASE VIRUS WHICH DIFFER IN VIRULENCE. JOURNAL OF GENERAL VIROLOGY, 27(JUN), 309-402. WoS6
  1973	GOWANS, E. J. (1973). IMPROVED METHOD OF AGAR PELLETED CELLS FOR ELECTRON-MICROSCOPY. MEDICAL LABORATORY TECHNOLOGY, 30(2), 113-115. WoS5 Europe PMC4
  -	Garcia Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk, B. (n.d.). 'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19.

• Book Chapters

  Year	Citation
  2017	Tomusange, K., Wijesundara, D., Gowans, E., & Grubor-Bauk, B. (2017). Human rhinovirus-A1 as an expression vector. In M. C. Ferran, & G. R. Skuse (Eds.), Recombinant Virus Vaccines: Methods and Protocols (Vol. 1581, pp. 181-201). UK: Humana Press. DOI
  2000	Burrell, C., Chisari, F., Gerlich, W., Gowans, E., Howard, C., Kann, M., & Marion, P. (2000). Taxomic Structure of the Family. In M. van Regenmortel, C. Fauquet, & D. Bishop (Eds.), Virus Taxonomy Classification and Nomenclature of Viruses (7 ed., pp. 325-334). San Diego, USA: Academic Press.

• Conference Papers

  Year	Citation
  2013	Torresi, J., Chin, R., Chua, B., Johnson, D., Earnest-Sliveira, L., Zeng, W., . . . Jackson, D. C. (2013). HEPATITIS C VLPS DELIVERED TO DENDRITIC CELLS BY A TLR2 TARGETING LIPOPEPTIDE RESULTS IN ENHANCED NEUTRALIZING ANTIBODY AND CELL-MEDIATED RESPONSES. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S496-S497). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV. DOI
  2008	Gowans, E. J., Jones, K. L., Latour, P. A., Chua, B. Y., Dinatale, I., Loudovaris, M., . . . Jackson, D. C. (2008). DENDRITIC CELL IMMUNOTHERAPY TO TREAT PATIENTS WITH PERSISTENT HCV INFECTION. In HEPATOLOGY Vol. 48 (pp. 1013A). San Francisco, CA: JOHN WILEY & SONS INC.
  2006	Woollard, D. J., Haqshenas, G., Dong, X., & Gowans, E. J. (2006). Detection of intrahepatic virus-specific T-cells in marmosets with resolved GBV-B infection. In JOURNAL OF CLINICAL VIROLOGY Vol. 36 (pp. S16). Paris, FRANCE: ELSEVIER SCIENCE BV. DOI
  2005	Woollard, D. J., Martyn, J. C., Lee, M. L., Jones, K. L., Ffrench, R. A., & Gowans, E. J. (2005). Investigation of a novel HCV recombinant baculovirus as a vaccine delivery system. In TISSUE ANTIGENS Vol. 66 (pp. 592-593). Melbourne, AUSTRALIA: BLACKWELL PUBLISHING.
  2002	Whiting, P. W., Gowans, E. J., Sloots, T. P., Mackay, I. M., Tillack, S., Harrison, M., . . . Crawford, D. H. G. (2002). The effects of vitamin B12 on hepatitis C virus replication. In GASTROENTEROLOGY Vol. 123 (pp. 74). W B SAUNDERS CO.
  2000	Crawford, D. H., Lott, W. B., Cooksley, G., HArrison, M., McDonald, G., Sloots, T., & Gowans, E. J. (2000). Effects of cobalamin on hepatitis C virus translation and replication.. In HEPATOLOGY Vol. 32 (pp. 359A). W B SAUNDERS CO.
  1993	ATKINS, G. J., GOWANS, E. J., & ASHMAN, L. K. (1993). HEPATITIS-B VIRUS RECEPTORS ON HEMATOPOIETIC-CELLS. In JOURNAL OF LEUKOCYTE BIOLOGY (pp. 46). FEDERATION AMER SOC EXP BIOL.
  1991	MACNAUGHTON, T. B., GOWANS, E. J., QIAO, M., & BURRELL, C. J. (1991). SIMULTANEOUS EXPRESSION FROM CDNA OF MARKERS OF HEPATITIS-DELTA VIRUS AND HEPADNAVIRUS INFECTION IN CONTINUOUS CELL-LINES. In F. B. Hollinger, S. M. Lemon, & H. Margolis (Eds.), VIRAL HEPATITIS AND LIVER DISEASE (pp. 465-468). HOUSTON, TX: WILLIAMS & WILKINS. WoS2
  1991	Jilbert, A. R., Gowans, E. J., Macnaughton, T. B., & Burrell, C. J. (1991). Characterization of a subgenomic HDV-specific poly(A)+ RNA species isolated from human hepatoma cells supporting HDV RNA replication.. In J. L. GERIN, R. H. PURCELL, & M. RIZZETTO (Eds.), Progress in clinical and biological research Vol. 364 (pp. 309-314). WASHINGTON, DC: WILEY-LISS, INC. Scopus6 WoS7 Europe PMC3
  1991	Gowans, E. J., Macnaughton, T. B., Jilbert, A. R., & Burrell, C. J. (1991). Cell culture model systems to study HDV expression, replication and pathogenesis.. In J. L. GERIN, R. H. PURCELL, & M. RIZZETTO (Eds.), Progress in clinical and biological research Vol. 364 (pp. 299-308). WASHINGTON, DC: WILEY-LISS, INC. Scopus9 WoS9 Europe PMC5
  1987	GOWANS, E. J., BAROUDY, B. M., KORBA, B. E., & GERIN, J. L. (1987). MOLECULAR MARKERS OF WHV AND HDV INFECTION AT THE LEVEL OF THE SINGLE CELL. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 23). WILEY-LISS.
  1987	NEGRO, F., GOWANS, E., WELLS, F., HOOFNAGLE, J., BONINO, F., BAROUDY, B., & GERIN, J. (1987). AN INSITU HYBRIDIZATION ASSAY FOR HEPATITIS-DELTA-VIRUS (HDV) RNA IN LIVER AND ITS CLINICAL UTILITY AS A MARKER OF HDV REPLICATION. In JOURNAL OF HEPATOLOGY Vol. 5 (pp. S48). MUNKSGAARD INT PUBL LTD. WoS2
  1987	KORBA, B., TENNANT, B., GOWANS, E., WELLS, F., CLARKE, R., & GERIN, J. (1987). INFECTION AND TISSUE TROPISM OF WHV DURING THE NATURAL COURSE OF EXPERIMENTAL VIRAL-INFECTION OF WOODCHUCKS. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 24). WILEY-LISS.
  1987	BAROUDY, B. M., FUERST, T. R., GOWANS, E. J., BRANCH, A. D., ROBERTSON, H. D., WELLS, F. V., . . . GERIN, J. L. (1987). MOLECULAR-BIOLOGY OF HEPATITIS-D VIRUS. In JOURNAL OF MEDICAL VIROLOGY Vol. 21 (pp. A35). WILEY-LISS. WoS1

• Conference Items

  Year	Citation
  2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Novel DNA vaccine formulations encoding secreted HCV-E1/E2 fused to the IMX313 oligomerisation domain are immunogenic in mice. Poster session presented at the meeting of 12th Annual Scientific Meeting of the Australian Centre for HIV and Hepatitis Virology.
  2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Novel DNA vaccine formulations encoding secreted HCV-E1/E2 fused to the IMX313 oligomerisation domain are immunogenic in mice. Poster session presented at the meeting of Adelaide Immunology Retreat. Nuriootpa.
  2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Novel DNA vaccine formulations encoding secreted HCV-E1/E2 fused to the IMX313 oligomerisation domain are immunogenic in mice. Poster session presented at the meeting of Florey Postgraduate Research Conference.
  2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Enhancing the immunogenicity of HCV vaccines by fusing E1/E2 to the IMX313P multimerization technology. Poster session presented at the meeting of 24th International Symposium on Hepatitis C Virus and Related Viruses. Hyannis, Cape Cod, Massachusetts, USA.
  2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Novel DNA vaccines encoding secreted HCV-E1/E2 fused to the IMX313 oligomerisation domain are immunogenic in mice. Poster session presented at the meeting of The Queen Elizabeth Hospital (TQEH) Research Day. Adeleide, Australia.
  2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Enhancing the immunogenicity of HCV vaccines by fusing E1/E2 to the IMX313P oligomerisation technology. Poster session presented at the meeting of 9th Australasian Virology Society Meeting.
  2016	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2016). A novel DNA-based virus-like particle (VLP) vaccine against hepatitis C.. Poster session presented at the meeting of Florey Postgraduate Research Conference.
  2016	Masavuli, M. G., Wijesundara, D. W., Grubor-Bauk, B., & Gowans, E. J. (2016). A DNA-based virus-like particle (VLP) vaccine against the hepatitis C virus. Poster session presented at the meeting of The Queen Elizabeth Hospital (TQEH) Research Day. Adelaide.
  2016	Tomusange, K., Wijesundara, D., Gummow, J., Gowans, E. J., & Grubor-Bauk, B. (2016). Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits protective HIV-specific immune responses. Poster session presented at the meeting of Abstracts of the 2016 Conference on HIV Research for Prevention (HIV R4P), as published in Aids Research and Human Retroviruses. Chicago, IL: Mary Ann Liebert. DOI
  2015	Masavuli, M. G., Grubor-Bauk, B. G., Wijesundara, D. K., & Gowans, E. J. (2015). A novel DNA-based virus-like particle (VLP) vaccine for hepatitis C virus. Poster session presented at the meeting of Florey Postgraduate Research Conference. AdelaIide.
  2015	Masavuli, M. G., Wijesundara, D. K., grubor-bauk, B., & gowans, E. G. (2015). A novel DNA-based virus-like particle vaccine for hepatitis C virus. Poster session presented at the meeting of The Queen Elizabeth Hospital (TQEH) Research Day 2015. Adelaide.
  2013	Loveland, B. E., Latour, P., Roberts, S. K., Gordon, A., Kemp, W., Kitson, M., . . . Gowans, E. J. (2013). A Phase I clinical trial of cellular immunotherapy for persistent Hepatitis C infection. Poster session presented at the meeting of Clinical and Experimental Pharmacology and Physiology. Hangzhou, Peoples Republic of China: Wiley-Blackwell.

• Theses

  Year	Citation
  2018	Masavuli, M. G. (2018). Novel DNA Vaccine Formulations Against Hepatitis C Virus. (PhD Thesis).

Teaching and Supervision

• Past Higher Degree by Research Supervision (University of Adelaide)

  Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
  2015 - 2019	Principal Supervisor	Pre-Clinical Evaluation of a Vaccination Strategy to Induce Liver Resident Memory T Cells against Hepatitis C Virus	Doctor of Philosophy	Doctorate	Full Time	Mr Zelalem Addis Mekonnen
  2015 - 2016	Principal Supervisor	Strategies for the development of recombinant porcine adenovirus-based vaccines against Hepatitis C virus.	Master of Philosophy (Medical Science)	Master	Full Time	Mr Harshwardhan Jagdale
  2014 - 2018	Principal Supervisor	Novel DNA Vaccine Formulations Against Hepatitis C Virus	Doctor of Philosophy	Doctorate	Full Time	Dr Makutiro Ghislain Masavuli
  2013 - 2016	Principal Supervisor	Novel Recombinant DNA and Live Virus Vaccines to Prevent or Control HIV-1 Infection	Doctor of Philosophy	Doctorate	Full Time	Mr Khamis Tomusange
  2012 - 2014	Principal Supervisor	Evaluating the Immuno-modulatory Effects of a Natural Adjuvant as a Novel Vaccine Strategy	Doctor of Philosophy	Doctorate	Full Time	Miss Tamsin Jade Garrod
  2012 - 2013	Principal Supervisor	Optimising DNA vaccine technology to prevent HIV-1 Infection	Doctor of Philosophy	Doctorate	Full Time	Miss Tessa Gargett
  2012 - 2017	Principal Supervisor	The Development of a Multi-Antigenic Cytolytic DNA Vaccine against HCV	Doctor of Philosophy	Doctorate	Full Time	Dr Jason Anthony Gummow
  2010 - 2012	Principal Supervisor	Suicide Genes in a Novel Vaccination Strategy for Hepatitis C	Master of Philosophy	Master	Full Time	Mr Hugh Francis Trahair

• Committee Memberships

  Date	Role	Committee	Institution	Country
  2015 - ongoing	Member	NHMRC Grant Assigner’s Panel	-	-
  2012 - ongoing	Chair	Strategic Research Directions Committee	Basil Hetzel Institute, The Queen Elizabeth Hospital	-
  2012 - ongoing	Member	BHI Policy Committee	-	-
  2012 - ongoing	Member	Local organising committee	Australian-Pacific Congress of Virology	-
  2012 - ongoing	Member	Microbiology Grant Review Panel	NHMRC	-
  2012 - 2014	Member	Advisory Committee for Biologicals, Therapeutic Goods Administration	-	-
  2005 - ongoing	Chair	Institutional Biosafety Committee	The Queen Elizabeth Hospital and Basil Hetzel Institute	Australia

• Memberships

  Date	Role	Membership	Country
  2014 - ongoing	-	Virus Research	-
  1999 - ongoing	-	Journal of Gastroenterology and Hepatology	-
  1998 - ongoing	-	Virus Genes	-

• Consulting/Advisories

  Date	Institution	Department	Organisation Type	Country
  2012 - ongoing	Viralytics Ltd	-	-	-

• Email: eric.gowans@adelaide.edu.au